| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 15.76B | 15.20B | 13.77B | 13.27B | 12.31B | 13.39B |
| Gross Profit | 8.06B | 7.60B | 6.61B | 6.67B | 5.80B | 6.68B |
| EBITDA | 10.90B | 9.49B | 11.22B | 8.66B | 5.24B | 6.70B |
| Net Income | 3.44B | 3.52B | 4.70B | 2.92B | 748.00M | 1.96B |
Balance Sheet | ||||||
| Total Assets | 120.83B | 118.75B | 118.24B | 125.03B | 114.35B | 104.22B |
| Cash, Cash Equivalents and Short-Term Investments | 1.08B | 261.00M | 801.00M | 3.68B | 620.00M | 673.00M |
| Total Debt | 61.81B | 61.00B | 59.88B | 63.66B | 58.68B | 53.15B |
| Total Liabilities | 83.67B | 81.85B | 79.88B | 86.03B | 80.23B | 70.82B |
| Stockholders Equity | 27.53B | 27.30B | 27.59B | 29.55B | 33.99B | 33.27B |
Cash Flow | ||||||
| Free Cash Flow | 3.80B | 2.08B | 1.34B | -881.00M | -352.00M | 966.00M |
| Operating Cash Flow | 8.59B | 7.35B | 7.70B | 7.27B | 6.38B | 6.89B |
| Investing Cash Flow | -5.99B | -6.46B | -6.91B | -12.29B | -7.01B | -7.71B |
| Financing Cash Flow | -3.50B | -1.52B | -3.87B | 8.09B | 487.00M | -88.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | C$159.99B | 17.39 | 12.34% | 5.80% | 21.76% | 37.87% | |
73 Outperform | C$36.37B | 18.16 | 9.91% | 5.44% | -5.92% | -12.92% | |
71 Outperform | C$92.26B | 24.46 | 12.80% | 4.41% | 1.37% | -24.17% | |
69 Neutral | C$15.80B | 25.03 | 8.74% | 2.99% | 1.11% | -13.38% | |
65 Neutral | $15.17B | 7.61 | 4.09% | 5.20% | 3.87% | -62.32% | |
61 Neutral | C$11.81B | 27.94 | 15.39% | 4.81% | -6.30% | -11.17% | |
54 Neutral | C$4.82B | -916.52 | 16.60% | 6.61% | -4.83% | -9.94% |